<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Business ethics</name>
          </item>
          <item>
            <name>Business expenses</name>
          </item>
          <item>
            <name>Business records</name>
          </item>
          <item>
            <name>Child health</name>
          </item>
          <item>
            <name>Civil actions and liability</name>
          </item>
          <item>
            <name>Corporate finance and management</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Department of Justice</name>
          </item>
          <item>
            <name>Department of Labor</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Drug, alcohol, tobacco use</name>
          </item>
          <item>
            <name>Education programs funding</name>
          </item>
          <item>
            <name>Elementary and secondary education</name>
          </item>
          <item>
            <name>Employment taxes</name>
          </item>
          <item>
            <name>Executive agency funding and structure</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Government studies and investigations</name>
          </item>
          <item>
            <name>Government trust funds</name>
          </item>
          <item>
            <name>Health programs administration and funding</name>
          </item>
          <item>
            <name>Health promotion and preventive care</name>
          </item>
          <item>
            <name>Income tax credits</name>
          </item>
          <item>
            <name>Marketing and advertising</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Preschool education</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>Research and development</name>
          </item>
          <item>
            <name>Securities</name>
          </item>
          <item>
            <name>Small business</name>
          </item>
          <item>
            <name>Wages and earnings</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <relatedBills>
      <item>
        <congress>115</congress>
        <latestAction>
          <actionDate>2018-04-17</actionDate>
          <text>Read twice and referred to the Committee on Finance.</text>
        </latestAction>
        <number>2691</number>
        <type>S</type>
        <latestTitle>Opioid Crisis Accountability Act of 2018</latestTitle>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <notes />
    <committees>
      <billCommittees>
        <item>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <date>2018-05-31T14:16:18Z</date>
                  <name>Referred to</name>
                </item>
              </activities>
              <name>Health Subcommittee</name>
              <systemCode>hswm02</systemCode>
            </item>
          </subcommittees>
          <type>Standing</type>
          <systemCode>hswm00</systemCode>
          <chamber>House</chamber>
          <name>Ways and Means Committee</name>
          <activities>
            <item>
              <date>2018-05-11T15:00:20Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
        <item>
          <subcommittees />
          <type>Standing</type>
          <systemCode>hsju00</systemCode>
          <chamber>House</chamber>
          <name>Judiciary Committee</name>
          <activities>
            <item>
              <date>2018-05-11T15:00:25Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
        <item>
          <subcommittees />
          <type>Standing</type>
          <systemCode>hsed00</systemCode>
          <chamber>House</chamber>
          <name>Education and Labor Committee</name>
          <activities>
            <item>
              <date>2018-05-11T15:00:15Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
        <item>
          <subcommittees />
          <type>Standing</type>
          <systemCode>hsif00</systemCode>
          <chamber>House</chamber>
          <name>Energy and Commerce Committee</name>
          <activities>
            <item>
              <date>2018-05-11T15:00:10Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <summaries>
      <billSummaries>
        <item>
          <text><![CDATA[<p><b>Opioid Crisis Accountability Act of 2018</b></p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a drug manufacturer from engaging in illegal marketing and distribution practices, including falsely advertising, promoting, or marketing that an opioid has no addiction-forming or addiction-sustaining qualities or risks, supplying states or communities with a quantity of opioids that is not medically necessary, or failing to report any order or pattern of orders that would cause a reasonable person to believe the opioids were not being dispensed in a medically reasonable manner.</p>]]></text>
          <actionDate>2018-05-11</actionDate>
          <actionDesc>Introduced in House</actionDesc>
          <name>Introduced in House</name>
          <lastSummaryUpdateDate>2019-08-20T18:09:18Z</lastSummaryUpdateDate>
          <versionCode>00</versionCode>
          <updateDate>2018-05-11T04:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
    <version>1.0.0</version>
    <originChamber>House</originChamber>
    <congress>115</congress>
    <latestAction>
      <actionDate>2018-05-31</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
      <links />
    </latestAction>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>7</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2018-05-31</actionDate>
        <committee>
          <name>Health Subcommittee</name>
          <systemCode>hswm02</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2018-05-11</actionDate>
        <committee>
          <name>Judiciary Committee</name>
          <systemCode>hsju00</systemCode>
        </committee>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <links />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
      </item>
      <item>
        <actionDate>2018-05-11</actionDate>
        <committee>
          <name>Ways and Means Committee</name>
          <systemCode>hswm00</systemCode>
        </committee>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <links />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
      </item>
      <item>
        <actionDate>2018-05-11</actionDate>
        <committee>
          <name>Education and Labor Committee</name>
          <systemCode>hsed00</systemCode>
        </committee>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <links />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
      </item>
      <item>
        <actionDate>2018-05-11</actionDate>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <links />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
      </item>
      <item>
        <actionDate>2018-05-11</actionDate>
        <committee />
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in House</text>
      </item>
      <item>
        <actionDate>2018-05-11</actionDate>
        <committee />
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in House</text>
      </item>
      <actionTypeCounts>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
        <placeholderTextForH>1</placeholderTextForH>
        <billReferrals>4</billReferrals>
      </actionTypeCounts>
    </actions>
    <createDate>2018-05-12T07:10:50Z</createDate>
    <laws />
    <titles>
      <item>
        <title>To hold pharmaceutical companies accountable for illegal marketing and distribution of opioid products and for their role in creating and exacerbating the opioid epidemic in the United States.</title>
        <chamberCode />
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
      </item>
      <item>
        <title>Opioid Crisis Accountability Act of 2018</title>
        <chamberCode />
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <chamberName />
      </item>
      <item>
        <title>Opioid Crisis Accountability Act of 2018</title>
        <chamberCode />
        <parentTitleType />
        <titleType>Display Title</titleType>
        <chamberName />
      </item>
      <item>
        <title>Opioid Crisis Accountability Act of 2018</title>
        <chamberCode />
        <parentTitleType />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <chamberName />
      </item>
    </titles>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 164, Number 77 (Friday, May 11, 2018)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Ms. GABBARD:H.R. 5782.Congress has the power to enact this legislation pursuantto the following:U.S. Constitution including Article 1, Section 8, Clause 3(Commerce Clause) and Article 1, Section 8, Clause 18(Necessary and Proper Clause).[Page H3935]</pre>]]></constitutionalAuthorityStatementText>
    <introducedDate>2018-05-11</introducedDate>
    <calendarNumbers />
    <recordedVotes />
    <textVersions>
      <item>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr5782ih/xml/BILLS-115hr5782ih.xml</url>
          </item>
        </formats>
        <date>2018-05-11T04:00:00Z</date>
        <type>Introduced in House</type>
      </item>
    </textVersions>
    <cosponsors>
      <item>
        <district>17</district>
        <state>CA</state>
        <sponsorshipDate>2018-05-11</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <identifiers>
          <lisID>2308</lisID>
          <gpoId />
          <bioguideId>K000389</bioguideId>
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <party>D</party>
        <lastName>Khanna</lastName>
        <bioguideId>K000389</bioguideId>
        <fullName>Rep. Khanna, Ro [D-CA-17]</fullName>
        <firstName>Ro</firstName>
      </item>
      <item>
        <district>7</district>
        <state>WA</state>
        <sponsorshipDate>2018-05-16</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <identifiers>
          <bioguideId>J000298</bioguideId>
          <lisID>2354</lisID>
          <gpoId />
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <party>D</party>
        <lastName>Jayapal</lastName>
        <bioguideId>J000298</bioguideId>
        <fullName>Rep. Jayapal, Pramila [D-WA-7]</fullName>
        <firstName>Pramila</firstName>
      </item>
      <item>
        <district>8</district>
        <state>MD</state>
        <sponsorshipDate>2018-11-06</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <identifiers>
          <lisID>2332</lisID>
          <gpoId />
          <bioguideId>R000606</bioguideId>
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <party>D</party>
        <lastName>Raskin</lastName>
        <bioguideId>R000606</bioguideId>
        <fullName>Rep. Raskin, Jamie [D-MD-8]</fullName>
        <firstName>Jamie</firstName>
      </item>
      <item>
        <district>0</district>
        <state>VT</state>
        <sponsorshipDate>2018-11-06</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <identifiers>
          <bioguideId>W000800</bioguideId>
          <lisID>1879</lisID>
          <gpoId>8204</gpoId>
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <party>D</party>
        <lastName>Welch</lastName>
        <bioguideId>W000800</bioguideId>
        <fullName>Rep. Welch, Peter [D-VT-At Large]</fullName>
        <firstName>Peter</firstName>
      </item>
      <item>
        <district>18</district>
        <state>TX</state>
        <sponsorshipDate>2018-11-20</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <identifiers>
          <lisID>588</lisID>
          <gpoId>8174</gpoId>
          <bioguideId>J000032</bioguideId>
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <party>D</party>
        <lastName>JACKSON LEE</lastName>
        <bioguideId>J000032</bioguideId>
        <fullName>Rep. Jackson Lee, Sheila [D-TX-18]</fullName>
        <firstName>SHEILA</firstName>
      </item>
    </cosponsors>
    <amendments />
    <billNumber>5782</billNumber>
    <updateDate>2019-11-15T21:43:17Z</updateDate>
    <cboCostEstimates />
    <title>Opioid Crisis Accountability Act of 2018</title>
    <committeeReports />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <sponsors>
      <item>
        <party>D</party>
        <district>2</district>
        <lastName>Gabbard</lastName>
        <firstName>Tulsi</firstName>
        <state>HI</state>
        <fullName>Rep. Gabbard, Tulsi [D-HI-2]</fullName>
        <identifiers>
          <lisID>2122</lisID>
          <gpoId />
          <bioguideId>G000571</bioguideId>
        </identifiers>
        <middleName />
        <bioguideId>G000571</bioguideId>
        <byRequestType />
      </item>
    </sponsors>
    <billType>HR</billType>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

